| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |